60 related articles for article (PubMed ID: 19348379)
1. Immunohistochemical detection of MDR proteins in Wilms' tumour.
Hodorova I; Rybarova S; Vecanova J; Plank L; Kluchova D
Bratisl Lek Listy; 2008; 109(12):564-7. PubMed ID: 19348379
[TBL] [Abstract][Full Text] [Related]
2. Relation between expression pattern of wild-type p53 and multidrug resistance proteins in human nephroblastomas.
Hodorová I; Rybárová S; Vecanová J; Solár P; Plank L; Mihalik J
Acta Histochem; 2013 Apr; 115(3):273-8. PubMed ID: 22925562
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of the lung resistance-related protein/major vault protein in the histological compartments of nephroblastomas.
Efferth T; Bode ME; Schulten HG; Thelen P; Granzen B; Beniers AJ; Mertens R; Gefeller O; Ringert RH; Jakse G; Fuzesi L
Int J Oncol; 2001 Jul; 19(1):163-8. PubMed ID: 11408938
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the multidrug resistance-related protein MRP1 in the histological compartments of nephroblastomas.
Efferth T; Thelen P; Schulten HG; Bode ME; Granzen B; Beniers AJ; Mertens R; Ringert RH; Gefeller O; Jakse G; Fuzesi L
Int J Oncol; 2001 Aug; 19(2):367-71. PubMed ID: 11445853
[TBL] [Abstract][Full Text] [Related]
5. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies.
Oue T; Yoneda A; Uehara S; Yamanaka H; Fukuzawa M
J Pediatr Surg; 2009 Feb; 44(2):377-80. PubMed ID: 19231538
[TBL] [Abstract][Full Text] [Related]
7. Expression of multidrug resistance-related protein (MRP-1), lung resistance-related protein (LRP) and topoisomerase-II (TOPO-II) in Wilms' tumor: immunohistochemical study using TMA methodology.
Fridman E; Skarda J; Pinthus JH; Ramon J; Mor Y
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):47-51. PubMed ID: 18795074
[TBL] [Abstract][Full Text] [Related]
8. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.
Rudas M; Filipits M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Pohl G
Breast Cancer Res Treat; 2003 Sep; 81(2):149-57. PubMed ID: 14572157
[TBL] [Abstract][Full Text] [Related]
9. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
Lahoti C; Thorner P; Malkin D; Yeger H
Am J Pathol; 1996 May; 148(5):1577-89. PubMed ID: 8623926
[TBL] [Abstract][Full Text] [Related]
12. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
13. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
Ora I; van Tinteren H; Bergeron C; de Kraker J;
Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of MRP1 protein in normal and hyperplastic human thyroid gland.
Hodorova I; Schmidtova K; Hajdukova M; Bobrov N; Rybarova S
Bratisl Lek Listy; 2004; 105(10-11):362-4. PubMed ID: 15658575
[TBL] [Abstract][Full Text] [Related]
15. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance proteins in renal cell carcinoma.
Hodorová I; Rybárová S; Solár P; Vecanová J; Mihalik J; Bohus P; Mellová Y; Kluchová D
Folia Biol (Praha); 2008; 54(6):187-92. PubMed ID: 19393132
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug resistance-associated proteins in rhabdomyosarcomas before and after chemotherapy: the relationship between lung resistance-related protein (LRP) and differentiation.
Klunder JW; Komdeur R; Van Der Graaf WT; De Bont EJ; Hoekstra HJ; Van Den Berg E; Molenaar WM
Hum Pathol; 2003 Feb; 34(2):150-5. PubMed ID: 12612883
[TBL] [Abstract][Full Text] [Related]
19. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
20. [Expression of multiple-drug resistant proteins in lung cancer].
Paredes-Lario A; Blanco-García C; Echenique-Elizondo M
Cir Esp; 2006 Jan; 79(1):46-56. PubMed ID: 16426533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
